Tags: febrilecoursesshort-termcystitispyelonephritis
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. | Summit’s upcoming cancer results, Recursion’s mixed data, and the next big obesity target - 14 days ago STAT+: AI drug firm Recursion seeks to move from survival to industry domination - about 1 month ago | |
| 2 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | ||
| 3 | Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois | ||
| 4 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | FDA Grants Breakthrough Device Designation for System Maintaining Weight Loss After GLP-1 - about 2 months ago | |
| 5 | Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location | ||
| 6 | Will Norman PV Tech Senior reporter. London | Recurrent Energy closes financing on 119MW Mexico PV plant - 7 months ago | |
| 7 | MedPage Today Staff MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | What Do New Breast Cancer Screening Recs Say? - 5 months ago | |
| 8 | Jennifer Henderson MedPage Today Enterprise & Investigative Writer. Works with MedPage Today. | ||
| 9 | Josh Kohn-Lindquist Motley Fool Contributor at The Motley Fool
Creator at Commonstock South Dakota | ||
| 10 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Axatilimab Shows Efficacy in Recurrent/Refractory GVHD - 9 months ago |